^
    BIOMARKER:

    STRN-ALK rearrangement

    i
    Other names: NBLST3, CD246, Anaplastic Lymphoma Kinase, Anaplastic Lymphoma Kinase (Ki-1), CD246 Antigen, Mutant Anaplastic Lymphoma Kinase, ALK, ALK Receptor Tyrosine Kinase, Anaplastic Lymphoma Receptor Tyrosine Kinase, ALK Tyrosine Kinase Receptor, STRN, Striatin, Protein Phosphatase 2 Regulatory Subunit B'''Alpha, Striatin Calmodulin Binding Protein, Striatin Calmodulin-Binding Protein, PPP2R6A, SG2NA, STRN1
    Entrez ID:
    238; 6801
    Related biomarkers:
    Expression
    Mutation
    CNA
    Fusion
    Others

    Associations

    Heatmap
    News
    Twitter
    Trials
    STRN-ALK rearrangement
    Mesothelioma
    crizotinib
    Sensitive: C4 – Case Studies
    STRN-ALK rearrangement
    Mesothelioma
    ABT 263
    Sensitive: D – Preclinical
    STRN-ALK rearrangement
    Mesothelioma
    cobimetinib
    Sensitive: D – Preclinical
    STRN-ALK rearrangement
    Mesothelioma
    ceritinib + PF-05212384
    Sensitive: D – Preclinical
    STRN-ALK rearrangement
    Mesothelioma
    ensartinib
    Sensitive: D – Preclinical
    STRN-ALK rearrangement
    Mesothelioma
    trametinib
    Sensitive: D – Preclinical
    STRN-ALK rearrangement
    Mesothelioma
    cobimetinib + ceritinib
    Sensitive: D – Preclinical
    STRN-ALK rearrangement
    Mesothelioma
    ceritinib
    Sensitive: D – Preclinical
    STRN-ALK rearrangement
    Mesothelioma
    brigatinib
    Sensitive: D – Preclinical
    STRN-ALK rearrangement
    Mesothelioma
    cisplatin + gemcitabine
    Resistant: D – Preclinical